Catalysts for $LLY
77 tracked
Nov 1, 2024
approval
MOUNJARO (TIRZEPATIDE) — FDA approval
ZEPBOUND
→
Nov 1, 2024
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Nov 1, 2024
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Oct 18, 2024
approval
ZEPBOUND (TIRZEPATIDE) — FDA approval
ZEPBOUND
→
Oct 18, 2024
approval
ZEPBOUND (TIRZEPATIDE) — FDA approval
ZEPBOUND
→
Oct 18, 2024
approval
ZEPBOUND (TIRZEPATIDE) — FDA approval
ZEPBOUND
→
Oct 18, 2024
approval
ZEPBOUND (TIRZEPATIDE) — FDA approval
ZEPBOUND
→
Oct 18, 2024
approval
ZEPBOUND (TIRZEPATIDE) — FDA approval
ZEPBOUND
→
Sep 27, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Sep 27, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Sep 27, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Sep 27, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Sep 13, 2024
approval
EBGLYSS (LEBRIKIZUMAB-LBKZ) — FDA approval
lebrikizumab
→
Jun 12, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Jun 12, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
May 29, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Apr 29, 2024
approval
OMVOH (MIRIKIZUMAB-MRKZ) — FDA approval
mirikizumab
→
Apr 10, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Apr 10, 2024
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Mar 28, 2024
approval
ZEPBOUND (TIRZEPATIDE) — FDA approval
ZEPBOUND
→
Nov 8, 2023
approval
ZEPBOUND (TIRZEPATIDE) — FDA approval
ZEPBOUND
→
Oct 26, 2023
approval
OMVOH (MIRIKIZUMAB-MRKZ) — FDA approval
mirikizumab
→
Jul 28, 2023
approval
MOUNJARO (TIRZEPATIDE) — FDA approval
ZEPBOUND
→
Jul 28, 2023
approval
MOUNJARO (TIRZEPATIDE) — FDA approval
ZEPBOUND
→
Nov 17, 2022
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Sep 21, 2022
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Sep 21, 2022
approval
RETEVMO (SELPERCATINIB) — FDA approval
selpercatinib
→
Jun 10, 2022
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
Jun 10, 2022
approval
TRULICITY (DULAGLUTIDE) — FDA approval
dulaglutide
→
May 13, 2022
approval
MOUNJARO (TIRZEPATIDE) — FDA approval
ZEPBOUND
→